Table 3 Clinical, neurological, and radiological findings in MS patients
Clinical data | All MS (n = 80) | RRMS (n = 68) | Progressive MS (n = 12) |
|---|---|---|---|
Disease Duration (years) | 2 (1–22) | 2 (1–22) | 6.5 (2–18) |
EDSS | 1.5 (1–6.5) | 1.5 (1–6) | 5.5 (1–6.5) |
ARR (relapses/year) | 1 (1–4) | 1 (1–4) | 1.5 (1–2) |
Site of lesion | Frequency and percent | ||
Periventricular | 13 (16.3%) | ||
Periventricular and Juxtacortical | 50 (62.5%) | ||
Others | 17 (21.3%) | ||
Number of lesions | Frequency and percent | ||
1–3 lesions | 42 (52.5%) | ||
4–9 lesions | 14 (17.5%) | ||
> = 10 lesions | 24 (30%) | ||
T1 Enhancement | Frequency and percent | ||
with T1 enhancement | 5 (6.3%) | ||
without T1 enhancement | 75 (93.8%) |